Comparative analysis of persistence and remission with guselkumab versus secukinumab and ixekizumab in the United States

• Autori principali: Maryia Zhdanava (Autore), Timothy Fitzgerald (Autore), Dominic Pilon (Autore), Rachel E. Teneralli (Autore), Aditi Shah (Autore), Lilian Diaz (Autore), Patrick Lefebvre (Autore), Steven R. Feldman (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

AbstractPurpose: Real-world data comparing long-term performance of interleukin (IL)-23 and IL-17 inhibitors in psoriasis are limited. This study compared treatment persistence and remission among patients initiating guselkumab versus IL-17 inhibitors.Methods: Adults with psoriasis initiating guselk...